Drug Kinetics – News and Features

Discover the latest in cystic fibrosis treatment, from CFTR modulators to ENaC blockers and emerging inhalable gene therapies.

Scientists have engineered a new type of sensor to monitor substances in the body over long stretches – measuring reactions for up to a week after being implanted in living rats.

Scientists demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the layers and orientation of the constituent molecules. This method could be used to help improve drug delivery.

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.

To make it easier for children to receive all of their vaccines, MIT researchers are working to develop microparticles that can release their payload weeks or months after being injected.

UVA Health researchers developed a non-invasive focused ultrasound method with microbubbles that stops the growth of cerebral cavernous malformations (CCMs) in mice. The approach temporarily opens the blood-brain barrier without drugs.

Researchers have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back.

Engineers at Brown University have designed a nanoscale drug delivery system that enhances the effectiveness of an antifungal drug against Candida species, including drug-resistant strains.

Researchers have developed a nanoparticle-infused gel that slowly releases "smells" that are attractive to coral larvae. Applying the gel to surfaces can increase coral larvae settlement by up to 20 times, aiding coral reef restoration.

Researchers at Empa have developed a flexible, tear-resistant material from the mycelium of an edible mushroom. Grown as a living system, the fungal composite forms films and stabilizes emulsions without chemical processing.